Share on Pinterest
Share with your friends


in the news

The biggest threat to healthcare

obesityKEY TAKEAWAY: The biggest threat to healthcare is NOT high drug prices but, rather obesity.  Unless further government action is taken, the global obesity rate will rise another 4% by 2025, according to a new report from the World Obesity Federation. Continue reading »

Time to challenge “fair balance” use ?

FTCJust how clueless is the FDA when it comes to how consumers are using the web for health information ?  Well the FDA still hasn’t issued social media guidelines, it’s only 3 years late, and consumers have pretty much moved on and are using the web in record numbers for health information.  I have always felt that the requirement for fair balance in search and social media is dumb.  Nobody is going to see a search result or Tweet and ask for an Rx without learning more about the prescription drug and the safety pages on drug websites are still among the most viewed pages.  Time to take the FTC recommendations and go back to the one-click rule (fair balance always one click away). Continue reading »

Patient Insights: Which insights are actionable?

UnknownKEY TAKEAWAY: DTC marketers can quickly be buried in patient insight data, but deciding which insights are actionable can be a challenge.  It’s essential that marketers establish processes to quantify patient insights so that they can be leveraged into opportunities. Continue reading »

EHRs are typically hard to use

UnknownKEY TAKEAWAY: Many doctors of spending several extra hours each day entering data to EHRs and EHRs often do not provide access to other clinical resources, so doctors need to use multiple systems. Continue reading »

The hype and bull in healthcare

lets-cut-bullshitPOST SUMMARY: The hype and bullshit in healthcare have never been deeper.  If healthcare is to evolve the simple formula is to make is revolve around patients not apps, website ratings or wearable devices. Continue reading »

AbbVie Wins Bidding War but looses

ar132761516213089POST SUMMARY: Pharmacyclics, the publicly traded cancer drug company is being sold to AbbVie for $21 billion. The amount stunned Wall Street, pushed aside one of the giants of the pharmaceutical sector, Johnson & Johnson, and set off a debate about whether AbbVie had paid too much.  In fact, they did pay too much. Continue reading »

Digital health: an oxymoron?

UnknownPOST SUMMARY: When it comes to managing your health no digital tool, app, website, is going to replace the knowledge and skill of your doctor.  It’s therefore essential that physicians learn to reach out to patients and treat the whole person at a time when our health care system is in the midst of a new era. Continue reading »

Statistics on mobile health mean little

Unknown-1“Nobody has figured out how to make consumers — patients — care about mobile health technologies. “And if we don’t [figure that out], m-health will be another tech bubble”. Dr. Joseph Kvedar, director of the Center for Connected Health. Continue reading »